Jason Sicklick

33PUBLICATIONS
92CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Oct 28, 2026
B cell subsets are associated with durable responses in distinct cancer types after immune checkpoint inhibition.

|Aug 27, 2026
Selective Internal Radiation Therapy (SIRT) for SDH-Deficient GIST Demonstrates Encouraging Durable Response Rates: An International Multicenter Case Series.

|Jul 30, 2026
Preoperative Avapritinib for Localized PDGFRA-Mutant GIST: Marked Pathologic Response, but Limited Feasibility at Standard Dosing.

|Jul 13, 2026
Radiographic Versus Pathology-Integrated Response for Assessing Optimal Surgical Timing After Neoadjuvant Imatinib in Patients With Locally Advanced KIT Exon 11-Mutant GIST.

|May 05, 2026
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy.

|Apr 20, 2026
Cytoreductive Surgery in Patients With Metastatic Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors.

Pageof 6

Frequent Collaborators

15 joint publications

Razelle Kurzrock

9 joint publications

Ryosuke Okamura

9 joint publications

Shumei Kato

6 joint publications

Suzanna Lee